EACR-AACR-SIC Conference 2015

Dear Colleagues, We are very pleased to welcome you to the EACR-AACR-SIC Special Conference:

Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic. EACR, AACR and SIC (Italian Cancer Society) have joined forces to organise this strong multidisciplinary meeting of cancer researchers and practising clinical experts as well as those focused on the development of new targeted therapeutics. Inhibitors targeting mutant proteins have shown unprecedented impact on the rate and duration of clinical responses. Despite these results, most cancers treated with single agents rapidly acquire resistance through a variety of mechanisms, severely limiting clinical benefit. This conference has presentations ranging across the identification of novel drug targets; non-oncogene addiction and synthetic lethality; discovery of drug resistance mechanisms; the development of combinatorial therapies; and related translational topics, across a wide spectrum of cancer types. We trust you will share our excitement about the unique scientific programme of this meeting and the impressive attendance of experts from many countries around the world. We thank you for choosing to take an active part in this ground-breaking conference and contribute your own invaluable expertise and unique perspective to its work. Richard Marais, Pasi Jänne, Riccardo Dolcetti, Conference Co-Chair (EACR) Conference Co-Chair (AACR) Conference Co-Chair (SIC) Special Conference